BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 20427871)

  • 1. Electrocardiographic manifestations of hyperkalemia in hemodialysis patients.
    Nemati E; Taheri S
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):471-7. PubMed ID: 20427871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiography and serum potassium before and after hemodialysis sessions.
    Tarif N; Yamani H; Bakhsh AJ; Al-Wakeel JS; Sulaimani F; Memon NA; Al Suwaida AK
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):47-53. PubMed ID: 18087122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of use of dates on serum potassium in nondiabetic hemodialysis patients.
    Siddiqi N; El Shahat O; Bokhari E; Roujouleh H; Hamid MH; Sheikh I; El-Sayed H; Saleh A; Seddik A
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1018-22. PubMed ID: 19861864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin system blockade is not associated with hyperkalemia in chronic hemodialysis patients.
    Lin HH; Yang YF; Chang JK; Ting IW; Kuo HL; Wang IK; Huang CC
    Ren Fail; 2009; 31(10):942-5. PubMed ID: 20030530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hyperkalemia among hemodialysis patients in Egypt.
    Khedr E; Abdelwhab S; El-Sharkawy M; Ali M; El Said K
    Ren Fail; 2009; 31(10):891-8. PubMed ID: 20030523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of electrocardiographic findings before and after hemodialysis session.
    Jebali H; Ghabi H; Mami I; Fatma LB; Smaoui W; Kaab BB; Krid M; Hlima MB; Ayed TB; Guermazi O; Mourali MS; Beji S; Chermiti M; Zied L; Kateb H; Hassan M; Hmida FB; Raies L; Zouaghi MK
    Saudi J Kidney Dis Transpl; 2020; 31(3):639-646. PubMed ID: 32655050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.
    Kaisar MO; Wiggins KJ; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Mudge DW; Bofinger A; Petrie JJ; Johnson DW
    Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt/V > 3.6.
    Supasyndh O; Satirapoj B; Seenamngoen S; Yongsiri S; Choovichian P; Vanichakarn S
    J Med Assoc Thai; 2009 May; 92(5):624-31. PubMed ID: 19459522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in QT intervals in patients with end-stage renal disease before and after hemodialysis.
    Malhis M; Al-Bitar S; Farhood S; Zaiat KA
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):460-5. PubMed ID: 20427869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkalaemia and haemodialysis patients: eletrocardiographic changes.
    Cobo Sánchez JL; Alconero Camarero AR; Casaus Pérez M; Maza Sota MA; Villa Llamazares C; Hiquera Roldán C; Menezo Viadero R; Alonso Nates R
    J Ren Care; 2007; 33(3):124-9. PubMed ID: 19160884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-wave and QRS complex measurements in patients undergoing hemodialysis.
    Drighil A; Madias JE; Yazidi A; Bennani M; Bennis A; Ramdan B; Tahiri A
    J Electrocardiol; 2008; 41(1):60.e1-7. PubMed ID: 17027839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium dynamics are attenuated in hyperkalemia and a determinant of QT adaptation in exercising hemodialysis patients.
    Tran CT; Bundgaard H; Ladefoged SD; Haunsø S; Kjeldsen K
    J Appl Physiol (1985); 2013 Aug; 115(4):498-504. PubMed ID: 23722704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acetate-free biofiltration with a potassium-profiled dialysate on the control of cardiac arrhythmias in patients at risk: a pilot study.
    Muñoz RI; Montenegro J; Salcedo A; Gallardo I; Martínez I; Quintanilla N; Saracho R; Lekuona I
    Hemodial Int; 2008 Jan; 12(1):108-13. PubMed ID: 18271851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of calcium and phosphorus metabolism in hemodialysis patients in Tehran Province, Iran.
    Mahdavi-Mazdeh M; Zamyadi M; Norouzi S; Heidary Rouchi A
    Iran J Kidney Dis; 2007 Jul; 1(1):25-8. PubMed ID: 19357440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of hyperkalaemia-associated repolarization abnormalities in end-stage renal disease.
    Green D; Green HD; New DI; Kalra PA
    Nephrol Dial Transplant; 2013 Jan; 28(1):99-105. PubMed ID: 22610985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk of arrhythmias in hemodialysis patients vs healthy people].
    Milone F; Urso S; Garozzo M; Memeo AM; Volpe G; Battaglia G
    G Ital Nefrol; 2004; 21 Suppl 30():S241-6. PubMed ID: 15750993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of nutritional status in patients undergoing maintenance hemodialysis: a single-center study from Iran.
    Afshar R; Sanavi S; Izadi-Khah A
    Saudi J Kidney Dis Transpl; 2007 Sep; 18(3):397-404. PubMed ID: 17679753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
    Movilli E; Camerini C; Gaggia P; Zubani R; Cancarini G
    Am J Nephrol; 2018; 48(2):79-86. PubMed ID: 30071530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium-lowering effect of albuterol for hyperkalemia in renal failure.
    Montoliu J; Lens XM; Revert L
    Arch Intern Med; 1987 Apr; 147(4):713-7. PubMed ID: 3827459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.